Literature DB >> 18392866

Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial.

M Masiá1, C Matoses, S Padilla, A Murcia, V Sánchez, I Romero, A Navarro, I Hernández, F Gutiérrez.   

Abstract

Most interventions aimed at diminishing the use of antimicrobials in hospitals have focussed on newly introduced antibiotics and very few have been randomly controlled. We evaluated the impact on antibiotic consumption of an intervention without restrictions in antibiotic use, focussed on commonly used antibiotics with a controlled randomized trial. All new prescriptions of levofloxacin, carbapenems, or vancomycin in hospitalized patients were randomized to an intervention or a control group. Intervention consisted of an antibiotic regimen counselling targeted to match local antibiotic guidelines, performed using only patients' charts. Clinical charts of patients assigned to the control group were reviewed daily by a pharmacist. The primary endpoint was a reduction in consumption of the targeted antibiotics. Two hundred seventy-eight prescriptions corresponding to 253 patients were included: 146 were assigned to the intervention and 132 to the control group. Total consumption of the targeted antibiotics (median [IQR]) was slightly lower in the intervention (8 [4-12] defined daily doses [DDDs] per patient) than in the control group (10 [6-16] DDDs per patient; p = 0.04). No differences in number of DDDs were observed when antibiotics of substitution were included (11.05 [6-18.2] vs 10 [6-16.5] in the intervention and control groups, respectively, p = 0.13). The total number of days on treatment with the targeted antibiotics was lower in the intervention (4 [3-7] days per patient) than in the control group (6 [4-10] days per patient; p = 0.002). Differences in number of days on treatment only reached statistical significance in the prescriptions of carbapenems. There were no differences between intervention and control groups in terms of number of deaths, hospital readmissions, length of hospital stay, or antibiotic costs. In this trial, an intervention without restrictions focussed on antimicrobial prescriptions of commonly used antibiotics in the hospital setting had a limited efficacy to reduce consumption and did not save costs. Future strategies to promote a more rational antimicrobial use should be evaluated with a randomized controlled design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392866     DOI: 10.1007/s10096-008-0482-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  36 in total

1.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.

Authors:  S K Fridkin; C D Steward; J R Edwards; E R Pryor; J E McGowan; L K Archibald; R P Gaynes; F C Tenover
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

Review 2.  The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.

Authors:  S P Stone; B S Cooper; C C Kibbler; B D Cookson; J A Roberts; G F Medley; G Duckworth; R Lai; S Ebrahim; E M Brown; P J Wiffen; P G Davey
Journal:  J Antimicrob Chemother       Date:  2007-03-26       Impact factor: 5.790

3.  Reducing antibiotic use in children: a randomized trial in 12 practices.

Authors:  J A Finkelstein; R L Davis; S F Dowell; J P Metlay; S B Soumerai; S L Rifas-Shiman; M Higham; Z Miller; I Miroshnik; A Pedan; R Platt
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

Review 4.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Authors:  D M Shlaes; D N Gerding; J F John; W A Craig; D L Bornstein; R A Duncan; M R Eckman; W E Farrer; W H Greene; V Lorian; S Levy; J E McGowan; S M Paul; J Ruskin; F C Tenover; C Watanakunakorn
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

5.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.

Authors:  V A Arason; K G Kristinsson; J A Sigurdsson; G Stefánsdóttir; S Mölstad; S Gudmundsson
Journal:  BMJ       Date:  1996-08-17

6.  Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet.

Authors:  John Macfarlane; William Holmes; Philip Gard; David Thornhill; Rosamund Macfarlane; Richard Hubbard
Journal:  BMJ       Date:  2002-01-12

7.  A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.

Authors:  T C Bailey; D J Ritchie; S T McMullin; M Kahn; R M Reichley; E Casabar; W Shannon; W C Dunagan
Journal:  Pharmacotherapy       Date:  1997 Mar-Apr       Impact factor: 4.705

8.  High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission.

Authors:  M H Samore; M K Magill; S C Alder; E Severina; L Morrison-De Boer; J L Lyon; K Carroll; J Leary; M B Stone; D Bradford; J Reading; A Tomasz; M A Sande
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

9.  Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study.

Authors:  J M Nava; F Bella; J Garau; J Lite; M A Morera; C Martí; D Fontanals; B Font; V Pineda; S Uriz
Journal:  Clin Infect Dis       Date:  1994-11       Impact factor: 9.079

10.  Impact of statewide program to promote appropriate antimicrobial drug use.

Authors:  Edward A Belongia; Mary Jo Knobloch; Burney A Kieke; Jeffrey P Davis; Carolyn Janette; Richard E Besser
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  7 in total

1.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

2.  Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study.

Authors:  Maher R Khdour; Hussein O Hallak; Mamoon A Aldeyab; Mowaffaq A Nasif; Aliaa M Khalili; Ahamad A Dallashi; Mohammad B Khofash; Michael G Scott
Journal:  Br J Clin Pharmacol       Date:  2018-01-23       Impact factor: 4.335

Review 3.  Interventions to improve antibiotic prescribing practices for hospital inpatients.

Authors:  Peter Davey; Charis A Marwick; Claire L Scott; Esmita Charani; Kirsty McNeil; Erwin Brown; Ian M Gould; Craig R Ramsay; Susan Michie
Journal:  Cochrane Database Syst Rev       Date:  2017-02-09

4.  A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-medium-sized hospitals.

Authors:  Pedro Mas-Morey; Marta Valle
Journal:  Eur J Hosp Pharm       Date:  2017-12-16

5.  Clinical outcomes in patients admitted to a hospitalist service exposed to an antimicrobial stewardship program - a retrospective matched cohort study.

Authors:  E Rennert-May; J Conly; G Chen; B Dalton
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-24       Impact factor: 4.887

6.  Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program at a Veterans Affairs Medical Center: A Six-Point Assessment.

Authors:  Haley J Morrill; Aisling R Caffrey; Melissa M Gaitanis; Kerry L LaPlante
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

7.  Interprofessional Collaboration between ICU Physicians, Staff Nurses, and Hospital Pharmacists Optimizes Antimicrobial Treatment and Improves Quality of Care and Economic Outcome.

Authors:  Stephan Schmid; Sophie Schlosser; Karsten Gülow; Vlad Pavel; Martina Müller; Alexander Kratzer
Journal:  Antibiotics (Basel)       Date:  2022-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.